240 related articles for article (PubMed ID: 16105905)
1. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
Loyant V; Jaffré A; Breton J; Baldi I; Vital A; Chapon F; Dutoit S; Lecluse Y; Loiseau H; Lebailly P; Gauduchon P
Mutagenesis; 2005 Sep; 20(5):365-73. PubMed ID: 16105905
[TBL] [Abstract][Full Text] [Related]
2. Brain tumours and exposure to pesticides: a case-control study in southwestern France.
Provost D; Cantagrel A; Lebailly P; Jaffré A; Loyant V; Loiseau H; Vital A; Brochard P; Baldi I
Occup Environ Med; 2007 Aug; 64(8):509-14. PubMed ID: 17537748
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
Greiner TC
Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
[TBL] [Abstract][Full Text] [Related]
4. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
6. High resolution melting for mutation scanning of TP53 exons 5-8.
Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations in workers exposed to occupational carcinogens.
Vähäkangas K
Hum Mutat; 2003 Mar; 21(3):240-51. PubMed ID: 12619109
[TBL] [Abstract][Full Text] [Related]
9. Ethnicity delineates different genetic pathways in malignant glioma.
Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
[TBL] [Abstract][Full Text] [Related]
10. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
11. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y; Bodmer WF
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
[TBL] [Abstract][Full Text] [Related]
12. Pesticide exposure of non-occupationally exposed subjects compared to some occupational exposure: a French pilot study.
Bouvier G; Blanchard O; Momas I; Seta N
Sci Total Environ; 2006 Jul; 366(1):74-91. PubMed ID: 16181660
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.
Schneider BG; John-Aryankalayil M; Rowsey JJ; Dushku N; Reid TW
Exp Eye Res; 2006 Jan; 82(1):91-8. PubMed ID: 16005868
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Olivier M; Langerød A; Carrieri P; Bergh J; Klaar S; Eyfjord J; Theillet C; Rodriguez C; Lidereau R; Bièche I; Varley J; Bignon Y; Uhrhammer N; Winqvist R; Jukkola-Vuorinen A; Niederacher D; Kato S; Ishioka C; Hainaut P; Børresen-Dale AL
Clin Cancer Res; 2006 Feb; 12(4):1157-67. PubMed ID: 16489069
[TBL] [Abstract][Full Text] [Related]
15. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
16. TP53 gene in blood plasma DNA of tumor patients.
Schlechte HH; Stelzer C; Weickmann S; Fleischhacker M; Schulze G
Ann N Y Acad Sci; 2004 Jun; 1022():61-9. PubMed ID: 15251941
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
19. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group.
Alguacil J; Kauppinen T; Porta M; Partanen T; Malats N; Kogevinas M; Benavides FG; Obiols J; Bernal F; Rifà J; Carrato A
Ann Occup Hyg; 2000 Aug; 44(5):391-403. PubMed ID: 10930502
[TBL] [Abstract][Full Text] [Related]
20. Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer.
Ecke TH; Schlechte HH; Gunia S; Lenk SV; Loening SA
Urol Oncol; 2008; 26(5):470-3. PubMed ID: 18367114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]